NCT04960670

Brief Summary

Childhood obesity is a strong predictor of adult obesity with health and economic consequences for the individual and society. Adiposity rebound (AR) is a rise in the Body Mass Index occurring between 3-7 years. Early adiposity rebound (EAR) occurs at a median age of 2 years and is a risk factor for later obesity. Events happening in "the first 1,000 days" play a role in obesity development. One of the key elements in this crucial time window is the gut microbiome, a highly dynamic organ that is sensitive to environmental exposure being linked to obesity development. Prenatal (dietary/lifestyle maternal factors and environmental exposure) and postnatal determinants (the type of feeding, sleep patterns, speed of growth) and environmental obesogenic pollutants may influence the infant microbial colonization, thus increasing the risk of EAR onset. LIMIT will holistically identify the longitudinal interplay between the intestinal microbiome and infant/maternal nutritional and lifestyle habits, environmental factors exposure and anthropometric measurements, in children with AR vs EAR, driving new mechanistic insights to create an EAR predictive model. The study will evaluate a group of 150 mother-infant pairs, during the first four years of life at different follow-up.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
8mo left

Started Dec 2021

Longer than P75 for all trials

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress87%
Dec 2021Dec 2026

First Submitted

Initial submission to the registry

June 10, 2021

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 14, 2021

Completed
5 months until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
4.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2025

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2026

Expected
Last Updated

July 14, 2021

Status Verified

July 1, 2021

Enrollment Period

4.1 years

First QC Date

June 10, 2021

Last Update Submit

July 1, 2021

Conditions

Keywords

childhood obesitymaternal lifestylegut microbiomeadiposity reboundfetal programmingfirst thousand dayspregnancybreastfeedingchildren nutritionendocrine disruptors chemicals

Outcome Measures

Primary Outcomes (3)

  • Infant's intestinal microbiome assessment - relative abundance

    To investigate the infant's intestinal microbiome development (0-48 months) by identifying the relative abundance of the dominant microbes.

    0-48 month

  • Infant's intestinal microbiome assessment - microbial diversity

    To investigate the infant's intestinal microbiome development (0-48 months) by assessing the microbial diversity.

    0-48 month

  • Infant's intestinal microbiome assessment - inter-individual variation

    To investigate the infant's intestinal microbiome development (0-48 months) by assessing the inter-individual variation.

    0-48 month

Secondary Outcomes (11)

  • Adiposity rebound identification

    0-48 month

  • Infant intestinal microbiome and pre-gestational weight status

    0-48 month

  • Infant intestinal microbiome and maternal weight gain

    0-48 month

  • Infant intestinal microbiome and maternal dietary habits

    0-48 month

  • Infant intestinal microbiome and maternal physical activity

    0-48 month

  • +6 more secondary outcomes

Study Arms (1)

Dyads

Mother/infant pairs will be evaluated for anthropometric parameters, prenatal (dietary/lifestyle maternal factors)/postnatal determinants (type of feeding, sleep patterns, speed of growth) before discharge and after different follow-up after birth. Infant urinary and stool samples will be collected and stored. The infant adiposity rebound will be monitored.

Other: Evaluation of microbiome and maternal/infant lifestyle

Interventions

Identification of the longitudinal interplay between the intestinal microbiome and infant/maternal nutritional and lifestyle habits, environmental factors exposure and anthropometric measurements, in children with adiposity rebound vs children with early adiposity rebound.

Dyads

Eligibility Criteria

Age1 Day - 48 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Mother and infant pairs.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Biospecimen

Retention: SAMPLES WITH DNA

* Infant stool samples for the gut microbiota analysis * Maternal blood samples for nutritional status evaluation. * Maternal urinary samples for endocrine disruptors chemicals. All biological samples will be collected and stored at -80°C until the analysis.

MeSH Terms

Conditions

Pediatric ObesityBreast Feeding

Condition Hierarchy (Ancestors)

ObesityOverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsFeeding BehaviorBehavior

Study Officials

  • Rachele De Giuseppe, PhD

    University of Pavia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ilaria Di Napoli, Dr

CONTACT

Hellas Cena, Prof

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 10, 2021

First Posted

July 14, 2021

Study Start

December 1, 2021

Primary Completion

December 31, 2025

Study Completion (Estimated)

December 31, 2026

Last Updated

July 14, 2021

Record last verified: 2021-07

Data Sharing

IPD Sharing
Will not share